Showing results (981-990 of 5,723) with videos related to
Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|June 6, 2022
UHRF1 modulates breast cancer cell growth via estrogen signalingGuosheng Luo, Quanhui Li, Miao Yu, et al.Medical Oncology (Northwood, London, England)|December 14, 2022
STRESS granule-associated RNA-binding protein CAPRIN1 drives cancer progression and regulates treatment response in nasopharyngeal carcinomaTe Yang, Long Huang, Haide Qin, et al.Medical Oncology (Northwood, London, England)|December 16, 2022
Social hobbies can increase self-esteem and quality of life in female breast cancer patients with type A personality trait: KRATOS studyAytug Cagirtekin, Ozgur TanriverdiMedical Oncology (Northwood, London, England)|December 17, 2022
Treatment of cervical cancer by electrochemotherapy with bleomycin, cisplatin, and calcium: an in vitro experimental studyGuney Gursoy, Meric Arda Esmekaya, Zehra CicekMedical Oncology (Northwood, London, England)|December 6, 2022
Investigating the anti-tumoral effect of yarrow (Achillea milllefolium) on the mice in which ehrlich solid tumor is createdGökçe Bağcı Uzun, Mehtap Nisari, Arzu Hanım Yay, et al.Medical Oncology (Northwood, London, England)|June 8, 2022
The effect of mesenchymal stromal cells ın the microenvironment on cancer developmentÖzlem Sağlam-Uçar, İrfan Değirmenci, Zehra Seda Halbutoğullari, et al.Medical Oncology (Northwood, London, England)|June 18, 2022
Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinomaShiqi Miao, Jing Song, Qingyuan Liu, et al.Medical Oncology (Northwood, London, England)|June 18, 2022
The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategiesHamed Hosseinalizadeh, Mehrdad Mahmoodpour, Ali Akbar Samadani, et al.Medical Oncology (Northwood, London, England)|September 25, 2020
Population mutation properties of tumor evolutionLeeYoung ParkMedical Oncology (Northwood, London, England)|January 4, 2021
LDLRAD2 promotes pancreatic cancer progression through Akt/mTOR signaling pathwayJunhe Li, Wei Huang, Qing Han, et al.Pageof 573